Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are in the business of developing, manufacturing and selling to our marketing partners pharmaceutical products that utilize our proprietary bioadhesive drug delivery technologies to treat various medical conditions. Our focus is drug delivery across mucosal membranes, an area where we have a rich heritage and proven capabilities. To date, we have developed and brought to market six products: five bioadhesive vaginal gel products that provide patient-friendly solutions for infertility, pregnancy support, amenorrhea, and other women's health conditions, and a bioadhesive buccal system for male hypogonadism. ... More ...
Analyst Info |
|
| Annual EPS Est: | $0.04 |
| Quarterly EPS Est: | 0.02 |
| PEG Ratio: | .01 |
|
Mean Recommendation: View Summary / View All |
1 |
Data is provided by Zacks Investment Research

